(2021). Everolimus/nivolumab: Severe acute respiratory syndrome Coronavirus-2 infection: case report. Reactions Weekly.
Citación estilo Chicago"Everolimus/nivolumab: Severe Acute Respiratory Syndrome Coronavirus-2 Infection: Case Report." Reactions Weekly 2021.
Cita MLA"Everolimus/nivolumab: Severe Acute Respiratory Syndrome Coronavirus-2 Infection: Case Report." Reactions Weekly 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.